In vitro Pharmacology

In the dynamic field of pharmaceutical research, in vitro pharmacology plays a pivotal role. It accelerates drug discovery through high-throughput screenings in controlled laboratory settings, identifying compounds with desired pharmacological effects, thus speeding the development of innovative therapeutics.

At Welab Barcelona, we take pride in our comprehensive capabilities and deep expertise in in vitro pharmacology assays. Our dedicated team possesses the knowledge, experience, and state-of-the-art equipment necessary to perform these assays with precision and reliability, ensuring that potential therapeutics are rigorously evaluated for their efficacy and safety.

Our expert team of researchers have deep experience in studying how a drug interacts with specific molecular targets, such as receptors, enzymes or ion channels at the cellular level or using isolated proteins or membranes to understand how a drug modulates biological activity leading to its therapeutic or adverse effects.

Dear colleagues, collaborators, and friends,

After more than 30 years of shared endeavours, in which we have grown personally and professionally, and with our emotions on the surface, we announce the closure of our company. We have travelled together through ups and downs, celebrated successes and overcome challenges as a team.

We extend our deepest gratitude to each of you for your dedication, passion, and commitment to a shared goal: discovering new treatments for the benefit and well-being of patients.

As we bid farewell, let’s cherish the memories we’ve created, the bonds we’ve formed, and the impact we’ve made together. Though our paths may diverge, the spirit of collaboration and camaraderie that defines our community will always endure.

We leave proud of the work accomplished and thank you for being an integral part of our journey, wishing you success in all your future challenges.

With heartfelt appreciation,

Welab’s team

We are proud to announce that Welab is partner of this new EU funded project.

In collaboration with 12 partners from 6 countries, Welab Barcelona is establishing the Antivirus Pandemic Preparedness EuropeAn pLatform (APPEAL), a European research initiative aimed at enhancing preparedness for future pandemics. This EU funded collaboration will establish a comprehensive program for the development of broad-spectrum antiviral drugs within a five year time frame ensuring drug affordability and accessibility to low income countries.
Link to the press release: https://lnkd.in/d-jmV2CS